Netarsudil
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 204 publications
The enantioselective total synthesis of ROCK-inhibitor (S)-Netarsudil (Rhopressa) via asymmetric organocatalysis.
Journal: Organic & biomolecular chemistry
Published: January 21, 2026
Reticular Honeycomb Epithelial Corneal Edema Associated With Netarsudil.
Journal: JAMA ophthalmology
Published: December 18, 2025
Phase III Prospective Randomised Study of Netarsudil and Concomitant Latanoprost Efficacy and Safety for Primary Open-Angle Glaucoma or Ocular Hypertension in Japan: J-ROCKET-2.
Journal: Advances in therapy
Published: December 08, 2025
Netarsudil and Corneal Edema: An Update and Review of the Literature.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: September 11, 2025
Efficacy, effectiveness, and safety of rho-kinase inhibitors in uveitic glaucoma and ocular hypertension secondary to uveitis: a systematic review and meta-analysis.
Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
Published: September 05, 2025
Netarsudil-associated conjunctival fragility.
Journal: American journal of ophthalmology case reports
Published: August 22, 2025
RhoKinase (ROCK) Inhibition as a Therapeutic Strategy for Pseudophakic Bullous Keratopathy: A Comprehensive Review.
Journal: Journal of clinical medicine
Published: July 27, 2025
A Comprehensive Review of the Role of Rho-Kinase Inhibitors in Corneal Diseases.
Journal: Life (Basel, Switzerland)
Published: June 24, 2025
Rho kinase inhibitors: a patent review (2017-2023).
Journal: Expert opinion on therapeutic patents
Published: June 24, 2025
Last Updated: 04/28/2026